NCT05167864View on ClinicalTrials.gov

Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area

NACompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Cosmetic Techniques
Interventions
DRUG

Onabotulinumtoxina for Injection

cosmetic injection into the glabella area (eyebrow area)

DRUG

Abobotulinumtoxina for Injection

cosmetic injection into the glabella area (eyebrow area)

DRUG

IncobotulinumtoxinA for Injection

cosmetic injection into the glabella area (eyebrow area)

DRUG

PrabotulinumtoxinA for Injection

cosmetic injection into the glabella area (eyebrow area)

Trial Locations (1)

19104

Penn Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER